WO2010120750A3 - Amorphous esomeprazole magnesium - Google Patents

Amorphous esomeprazole magnesium Download PDF

Info

Publication number
WO2010120750A3
WO2010120750A3 PCT/US2010/030855 US2010030855W WO2010120750A3 WO 2010120750 A3 WO2010120750 A3 WO 2010120750A3 US 2010030855 W US2010030855 W US 2010030855W WO 2010120750 A3 WO2010120750 A3 WO 2010120750A3
Authority
WO
WIPO (PCT)
Prior art keywords
esomeprazole magnesium
amorphous esomeprazole
amorphous
magnesium
processes
Prior art date
Application number
PCT/US2010/030855
Other languages
French (fr)
Other versions
WO2010120750A2 (en
Inventor
Srinivasa Reddy Bhimavarapu
Sree Naga Venkata Lakshmi Vara Prasad Vakamudi
Ravi Ram Chandra Sekhar Elati
Vijaya Bhaskar Bolugoddu
Original Assignee
Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc. filed Critical Dr. Reddy's Laboratories Ltd.
Publication of WO2010120750A2 publication Critical patent/WO2010120750A2/en
Publication of WO2010120750A3 publication Critical patent/WO2010120750A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Processes for preparing amorphous esomeprazole magnesium.
PCT/US2010/030855 2009-04-14 2010-04-13 Amorphous esomeprazole magnesium WO2010120750A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN852CH2009 2009-04-14
IN852/CHE/2009 2009-04-14
US22042209P 2009-06-25 2009-06-25
US61/220,422 2009-06-25

Publications (2)

Publication Number Publication Date
WO2010120750A2 WO2010120750A2 (en) 2010-10-21
WO2010120750A3 true WO2010120750A3 (en) 2011-04-21

Family

ID=42983098

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/030855 WO2010120750A2 (en) 2009-04-14 2010-04-13 Amorphous esomeprazole magnesium

Country Status (1)

Country Link
WO (1) WO2010120750A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004020436A1 (en) * 2002-08-30 2004-03-11 Reddy's Laboratories Limited Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
US20070043085A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of amorphous form of neutral esomeprazole
US20070259921A1 (en) * 2006-05-04 2007-11-08 Vijayabhaskar Bolugoddu Polymorphic forms of esomeprazole sodium
US20070287839A1 (en) * 2006-06-09 2007-12-13 Apotex Pharmachem Inc. Novel process for the preparation of esomeprazole and salts thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004020436A1 (en) * 2002-08-30 2004-03-11 Reddy's Laboratories Limited Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
US20070043085A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of amorphous form of neutral esomeprazole
US20070259921A1 (en) * 2006-05-04 2007-11-08 Vijayabhaskar Bolugoddu Polymorphic forms of esomeprazole sodium
US20070287839A1 (en) * 2006-06-09 2007-12-13 Apotex Pharmachem Inc. Novel process for the preparation of esomeprazole and salts thereof

Also Published As

Publication number Publication date
WO2010120750A2 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
AP2011005533A0 (en) Anastomat for circumcision.
EP2463313A4 (en) Method for producing copolymer
EP2803466B8 (en) Molding apparatus
AP2012006052A0 (en) Improved method for synthesizing pirfenidone.
IL214600A0 (en) Process for preparing substituted 2-nitrobiphenyls
EP2464650A4 (en) Processes for preparing pemetrexed
IL220357A0 (en) Process for preparing substituted 1-o-acyl-2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranoses
IL208540A0 (en) Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters
ZA201102424B (en) Process for preparing 2-alkyl-3-aroyl-5-nitro-benzofurans
AP2010005460A0 (en) Device for producing chocolate.
EP2328900A4 (en) PROCESS FOR MAKING MORPHINAN-6 alpha-OLS
IL218140A0 (en) Process for preparing 1-phenylpyrazoles
IL208514A0 (en) Process for preparing substituted biphenylanilides
ZA201009104B (en) Process for making substituted 2-amino-thiazolones
EP2346661A4 (en) Forming methods
SI2281801T1 (en) Process for obtaining 3,3-diphenylpropylamines
IL207222A0 (en) Process for preparing hebivolol
EP2474608A4 (en) Process for soil recuperation
WO2010120750A3 (en) Amorphous esomeprazole magnesium
AU2009906108A0 (en) Microbial Controlled Release Method
AU2009904078A0 (en) Process for magnesium production
AU2009905507A0 (en) Arsenic removal
AU2009900273A0 (en) Extraction process
AU2008900396A0 (en) Process
AU2008902239A0 (en) Process

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10764997

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10764997

Country of ref document: EP

Kind code of ref document: A2